Acute effects of butyrate on intestinal permeability in patients with irritable bowel syndrome assessed by a novel colonoscopy research model

Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder for which effective treatment strategies are insufficient. Butyrate, a microbiota-derived short-chain fatty acid believed to strengthen the intestinal barrier function, might be a potential new treatment option. This study aimed...

Full description

Saved in:
Bibliographic Details
Main Authors: Mathias W. Scharf, Richard A. Forsgård, Samira B. R. Prado, John-Peter Ganda Mall, Dirk Repsilber, Robert J. Brummer, Tatiana M. Marques, Rebecca Wall
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Gut Microbes
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19490976.2025.2545414
Tags: Add Tag
No Tags, Be the first to tag this record!